Literature DB >> 29791049

2-Benzoylpyridine Ligand Complexation with Gold Critical for Propargyl Ester-Based Protein Labeling.

Yixuan Lin1,2, Kenward Vong1, Koji Matsuoka2, Katsunori Tanaka1,3,4.   

Abstract

In previously reported work, AuIII complexes coordinated with 2-benzoylpyridine ligand, BPy-Au, were prebound to a protein and used to discover a novel protein-directed labeling approach with propargyl ester functional groups. In this work, further examination discovered that gold catalysts devoid of the 2-benzoylpyridine ligand (e.g., NaAuCl4) had significantly reduced levels of protein labeling. Mechanistic investigations then revealed that BPy-Au and propargyl esters undergo a rare example of C(sp2 )-C(sp) aryl-alkynyl cross-coupling, likely through spontaneous reductive elimination. Overall, these observations appear to suggest that BPy-Au-mediated, propargyl ester-based protein labeling acts via an activated ester intermediate, which contributes to our understanding of this process and will aid the expansion/optimization of gold-catalyst usage in future bioconjugation applications, especially in vivo.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  alkynes; amides; cross coupling; gold catalysis; protein conjugation

Mesh:

Substances:

Year:  2018        PMID: 29791049     DOI: 10.1002/chem.201802058

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  4 in total

1.  Tuning Cyclometalated Gold(III) for Cysteine Arylation and Ligand-Directed Bioconjugation.

Authors:  Sailajah Gukathasan; Sean Parkin; Esther P Black; Samuel G Awuah
Journal:  Inorg Chem       Date:  2021-08-17       Impact factor: 5.165

Review 2.  Unlocking the therapeutic potential of artificial metalloenzymes.

Authors:  Katsunori Tanaka; Kenward Vong
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2020       Impact factor: 3.493

3.  Disrupting tumor onset and growth via selective cell tagging (SeCT) therapy.

Authors:  Kenward Vong; Tsuyoshi Tahara; Sayaka Urano; Igor Nasibullin; Kazuki Tsubokura; Yoichi Nakao; Almira Kurbangalieva; Hirotaka Onoe; Yasuyoshi Watanabe; Katsunori Tanaka
Journal:  Sci Adv       Date:  2021-04-23       Impact factor: 14.136

4.  Bioorthogonal release of anticancer drugs via gold-triggered 2-alkynylbenzamide cyclization.

Authors:  Kenward Vong; Tomoya Yamamoto; Tsung-Che Chang; Katsunori Tanaka
Journal:  Chem Sci       Date:  2020-09-02       Impact factor: 9.825

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.